K Pharma
Latest round
- Series C
Last raised
- May 2022
Total raised
- $12M
Investors
- 5
About K Pharma
Based in Tokyo, Japan, and founded in 2016, K Pharma, Inc. is a pharmaceutical company that researches, develops, and manufactures medicinal drugs and pharmaceutical products. In May 2022, K Pharma, Inc. As of May 2022, Hiroaki Fukushima is the CEO of K Pharma, Inc. The product line of K Pharma includes regenerative medicine and pharmaceuticals, which acts as a therapeutic tool for cerebral infarctions, and spinal cord injuries.
Who invested in K Pharma
5 investors across 1 round
See all investors in K Pharma
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series C
May 24, 2022
Amount
$12M
Investors
Questions about K Pharma
Who invested in K Pharma?
K Pharma has 5 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has K Pharma raised?
K Pharma has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did K Pharma last raise money?
K Pharma's most recent round on record is a Series C, in May 2022.
What does K Pharma do?
Based in Tokyo, Japan, and founded in 2016, K Pharma, Inc.
Where is K Pharma headquartered?
K Pharma is headquartered in Tokyo, Japan.
Which VCs invest in companies like K Pharma?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at K Pharma's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series C
Raising like K Pharma? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.